ClinVar Miner

Submissions for variant NM_000071.2(CBS):c.430G>A (p.Glu144Lys) (rs121964966)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Counsyl RCV000169074 SCV000220242 likely pathogenic Classic homocystinuria 2014-04-14 criteria provided, single submitter literature only
EGL Genetic Diagnostics, Eurofins Clinical Diagnostics RCV000723427 SCV000331006 pathogenic not provided 2015-11-18 criteria provided, single submitter clinical testing
Invitae RCV000169074 SCV000649837 likely pathogenic Classic homocystinuria 2020-06-29 criteria provided, single submitter clinical testing This sequence change replaces glutamic acid with lysine at codon 144 of the CBS protein (p.Glu144Lys). The glutamic acid residue is highly conserved and there is a small physicochemical difference between glutamic acid and lysine. This variant is present in population databases (rs121964966, ExAC 0.006%). This variant has been reported to co-occur in cis with the p.Arg439Gln variant in three individuals affected with homocystinuria (PMID: 9156316, 12124992). This variant has also been reported to co-occur in combination or in trans with other pathogenic variants in individuals with homocystinuria (PMID: 12124992, 7611293, 10215408). ClinVar contains an entry for this variant (Variation ID: 122). Experimental studies have shown that this variant severely impairs CBS enzyme activity in bacterial and yeast but not in higher eukaryotic cell systems (PMID: 22267502, 20506325, 25331909). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.
CeGaT Praxis fuer Humangenetik Tuebingen RCV000723427 SCV001246795 pathogenic not provided 2018-08-01 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001251284 SCV001426817 pathogenic Homocystinuria 2020-07-24 criteria provided, single submitter clinical testing Variant summary: CBS c.430G>A (p.Glu144Lys) results in a conservative amino acid change located in the Pyridoxal-phosphate dependent enzyme (IPR001926) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2.8e-05 in 250114 control chromosomes. c.430G>A has been reported in the literature in multiple individuals affected with Homocystinuria (e.g. Shih_1995, Gordon_1998, Janosik_2001, Guastadnes_2002,Kozich_2010). These data indicate that the variant is very likely to be associated with disease. In several of these cases, the variant has been reported to co-occur in cis with another variant that is cited as pathogenic (e.g. c.463G>A, p.A155T in Janosik_2001). Multiple publications report contrasting experimental evidence evaluating an impact on protein function. The variant was found to result in significantly reduced enzyme activtiy in yeast and bacterial cell lines (e.g. Gordon_1998, Kozich_2010, Mayfield_2012) but had no significant damaging effects in experiments in a mammalian cell line (Melenovska_2014). Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories cited the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen RCV000723427 SCV001480070 pathogenic not provided 2021-02-01 criteria provided, single submitter clinical testing
GeneDx RCV000723427 SCV001757529 pathogenic not provided 2019-11-04 criteria provided, single submitter clinical testing Not observed at a significant frequency in large population cohorts (Lek et al., 2016); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 12124992, 25331909, 10215408, 20567906, 9156316, 11359213, 11748855, 15365998, 14722927, 7611293, 20506325, 22267502, 31301157)
OMIM RCV000000144 SCV000020287 pathogenic Homocystinuria, pyridoxine-responsive 1995-07-01 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.